Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

समान संसाधन

• Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
  द्वारा: Shogo Amano, और अन्य
  प्रकाशित: (2020-07-01)
• Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
  द्वारा: Shinoda, Shuhei, और अन्य
  प्रकाशित: (2018)
• Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
  द्वारा: Harima, Hirofumi, और अन्य
  प्रकाशित: (2016)
• Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
  द्वारा: Yamamoto, Naoki, और अन्य
  प्रकाशित: (2016)
• Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
  द्वारा: Saeki, Issei, और अन्य
  प्रकाशित: (2016)